US 7815921
Cytocapacity test for the prediction of the hematopoietic recovery, neutropenic fever, and antimicrobial treatment following high-dose cytotoxic chemotherapy
granted A61PA61P1/04A61P11/00
Quick answer
US patent 7815921 (Cytocapacity test for the prediction of the hematopoietic recovery, neutropenic fever, and antimicrobial treatment following high-dose cytotoxic chemotherapy) held by Ludwig-Maximilians-Universitat Munchen expires Mon Oct 14 2030 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Ludwig-Maximilians-Universitat Munchen
- Grant date
- Tue Oct 19 2010 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Oct 14 2030 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 24
- CPC classes
- A61P, A61P1/04, A61P11/00, A61P31/04, A61P31/10